Due to that the administration of thrombolysis might decrease disease severity and improve prognosis in AIS patients, the effect of lnc‐ITSN1‐2 on disease severity, inflammation, and RFS in AIS patients might be influenced. Here, ITSN1 is linked to androgen insensitivity syndrome.